On September 15, 2015 Foundation Medicine, Inc. (NASDAQ:FMI) reported the expansion of its suite of molecular information-based products with GeneKitTM, a genomics solutions portal for pathologists (Press release, Foundation Medicine, SEP 15, 2015, View Source [SID:1234507470]). Uniquely differentiated by the power of FoundationCORETM, Foundation Medicine’s ever-growing comprehensive cancer genomics knowledgebase of more than 50,000 genomic profiles, GeneKit facilitates the interpretation of genomic data generated by pathologists from targeted next generation sequencing (NGS) and "hot spot" assays. This integration will help pathologists to more effectively support clinical diagnosis and treatment strategies via the rapid interpretation and efficient reporting of genomic information to oncology care teams.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
"To ensure that molecular information is used to inform therapeutic decisions and improve patient care, we are offering pathologists a sophisticated clinical interpretation system. GeneKit will allow pathologists to assess a patient’s specific tumor alterations against a knowledgebase of curated genomic variants, relevant scientific research, targeted therapy and clinical trial information, enabling the creation of actionable reports in a timely fashion for care teams," said David J. Daly, chief commercial officer of Foundation Medicine. "Today, a large number of institutions use manual interpretation procedures that can be incredibly arduous, technical and time-consuming. GeneKit overcomes these challenges of manual reporting and furnishes pathologists with highly relevant clinical and scientific data for the betterment of patient care."
Since hotspot panels are most widely used in pathology laboratories, GeneKit has been designed to seamlessly integrate into a pathologist’s standard workflow. GeneKit differs from other pathology reporting tools because of the following key features:
Integrates with any NGS assay that interrogates the variant status of up to 50 cancer-related genes that are known to be involved in the development, progression and/or treatment of cancers;
Relies upon FoundationCORE, Foundation Medicine’s knowledgebase of comprehensive genomic cancer information;
Efficiently and rapidly organizes and reports information on up to 50 genes using data from FoundationCORE, as well the customer’s proprietary data;
Easily integrates with other IT systems;
Offers a user-friendly interface that gives pathologists customized reporting options; and,
Provides a reflex option to Foundation Medicine’s comprehensive genomic profiling assays, FoundationOne and FoundationOne Heme.
GeneKit is a cloud-based software solution and is a component of Foundation Medicine’s molecular information-based suite of decision support solutions. GeneKit complements Interactive Cancer Explorer (ICE 2) with PatientMatchTM, the company’s innovative physician-facing decision support portal. Together, GeneKit and ICE 2 provide an unparalleled offering of molecular information-based solutions that empower cancer care teams to make informed diagnostic and therapeutic care choices based on the unique genomic drivers of each person’s cancer.